---
title: "Lifeon Pharmaceutical: Sodium Docetaxel has received approval for the active pharmaceutical ingredient listing application"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242178178.md"
description: "According to the Zhitong Finance APP, Lifeon Pharmaceutical announced that the company has received the \"Approval Notice for the Market Application of Chemical Raw Materials\" for Docusate Sodium issued by the National Medical Products Administration. The announcement shows that Docusate Sodium is an anionic surfactant that lubricates the intestines for bowel movements, and its formulation, Docusate Sodium Tablets, is used for chronic functional constipation"
datetime: "2025-05-28T10:22:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242178178.md)
  - [en](https://longbridge.com/en/news/242178178.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242178178.md)
generator: "portal-rs"
---

# Lifeon Pharmaceutical: Sodium Docetaxel has received approval for the active pharmaceutical ingredient listing application

According to the Zhitong Finance APP, Lifeon Pharmaceutical (003020.SZ) announced that the company has received the "Approval Notice for the Market Application of Chemical Raw Materials" for Docusate Sodium issued by the National Medical Products Administration. The announcement shows that Docusate Sodium is an anionic surfactant that lubricates the intestines for bowel movements. Its formulation, Docusate Sodium Tablets, is used for chronic functional constipation

### Related Stocks

- [003020.CN](https://longbridge.com/en/quote/003020.CN.md)

## Related News & Research

- [Chinese Pharma Companies Plan Hong Kong Listings](https://longbridge.com/en/news/297979501.md)
- [Grace Therapeutics CEO presents at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297910585.md)
- [Kyntra Bio CEO presents at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297778123.md)
- [StrategX Elements extends non-brokered private placement deadline to Sept. 30, 2026](https://longbridge.com/en/news/297583968.md)
- [Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President](https://longbridge.com/en/news/297630906.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**